Otonomy To Report Fourth Quarter And Full Year 2016 Financial Results And Provide Corporate Update Post author:Sam Post published:February 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Here???s Where Jobs in Shrinking Life Sciences Marketing Departments Are Headed February 19, 2017 Why Teva's Stock Could Crash Another 50% November 7, 2017 Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017